Heron Therapeuti Valuation
| HRTX Stock | USD 1.19 0.03 2.59% |
Today, the firm appears to be fairly valued. Heron Therapeuti retains a regular Real Value of $1.17 per share. The prevalent price of the firm is $1.19. Our model calculates the value of Heron Therapeuti from evaluating the firm fundamentals such as Return On Asset of -0.0231, current valuation of 288.35 M, and Return On Equity of -24.09 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Heron Therapeuti's valuation include:
Price Book 12.6037 | Enterprise Value 288.3 M | Enterprise Value Ebitda (1.55) | Price Sales 1.314 | Enterprise Value Revenue 2.0935 |
Fairly Valued
Today
Please note that Heron Therapeuti's price fluctuation is extremely dangerous at this time. Calculation of the real value of Heron Therapeuti is based on 3 months time horizon. Increasing Heron Therapeuti's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Heron Therapeuti is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heron Stock. However, Heron Therapeuti's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.19 | Real 1.17 | Target 7.3 | Hype 1.19 | Naive 1.23 |
The intrinsic value of Heron Therapeuti's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heron Therapeuti's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heron Therapeuti helps investors to forecast how Heron stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heron Therapeuti more accurately as focusing exclusively on Heron Therapeuti's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Heron Therapeuti's intrinsic value based on its ongoing forecasts of Heron Therapeuti's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Heron Therapeuti's closest peers.
Heron Therapeuti Cash |
|
Heron Valuation Trend
Analysing the historical paterns of Heron Therapeuti's enterprise value and its market capitalization is a good way to estimate and gauge the value of Heron Therapeuti over time and is usually enough for investors to make rational market timing decisions.
Heron Therapeuti Total Value Analysis
Heron Therapeuti is currently anticipated to have valuation of 288.35 M with market capitalization of 180.99 M, debt of 179.63 M, and cash on hands of 83.54 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Heron Therapeuti fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
288.35 M | 180.99 M | 179.63 M | 83.54 M |
Heron Therapeuti Investor Information
About 82.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.16. Heron Therapeuti had not issued any dividends in recent years. The entity had 1:20 split on the 13th of January 2014. Heron Therapeuti may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Heron Therapeuti Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Heron Therapeuti has an asset utilization ratio of 57.1 percent. This suggests that the Company is making $0.57 for each dollar of assets. An increasing asset utilization means that Heron Therapeuti is more efficient with each dollar of assets it utilizes for everyday operations.Heron Therapeuti Ownership Allocation
Heron Therapeuti has a total of 152.1 Million outstanding shares. The majority of Heron Therapeuti outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Heron Therapeuti to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Heron Therapeuti. Please pay attention to any change in the institutional holdings of Heron Therapeuti as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Heron Therapeuti Profitability Analysis
The company reported the previous year's revenue of 127.04 M. Net Loss for the year was (110.56 M) with loss before overhead, payroll, taxes, and interest of (50.51 M).About Heron Therapeuti Valuation
Our relative valuation model uses a comparative analysis of Heron Therapeuti. We calculate exposure to Heron Therapeuti's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heron Therapeuti's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 61.9 M | 65 M | |
| Pretax Profit Margin | (0.87) | (0.91) | |
| Operating Profit Margin | (0.87) | (0.91) | |
| Net Loss | (0.87) | (0.91) | |
| Gross Profit Margin | 0.49 | 0.51 |
Heron Therapeuti Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 138.1 M |
Heron Therapeuti Current Valuation Indicators
Valuation refers to the process of determining the present value of Heron Therapeuti and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Heron we look at many different elements of the entity such as Heron's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Heron Therapeuti, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Heron Therapeuti's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Heron Therapeuti's worth.Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.